Institution: The University of Auckland
Faculty: Faculty of Science
Department: School of Psychology
Focus Area: Drugs and Addiction
Centre: Centre for Brain Research
Key Components:
VTA (Ventral Tegmental Area)
NAcc (Nucleus Accumbens)
Mechanism: Recreational drugs increase dopamine release in NAcc.
Drug Classifications:
Depressants: Alcohol, benzodiazepines, barbiturates
Stimulants: Cocaine, nicotine
Amphetamines: Methamphetamine (speed, meth), MDMA (Ecstasy)
Hallucinogens: LSD, mescaline, psilocybin, PCP
Cannabinoids: Marijuana, hash
Opiates: Morphine, codeine, heroin
Prescribed Drugs: Antipsychotics, antidepressants, anxiolytics
Significant Structures:
Neocortex
Hippocampus
Caudate nucleus
Nucleus accumbens
Substantia nigra
Amygdala
Neurotransmitter Distribution: Dopaminergic neurons and their axons show coordinate distributions to key brain structures linked to reward mechanism.
Apparatus: Operant chamber with a lever used for studying reinforcing brain stimulation.
Process: Lever activation leads to electrical stimulation and dopamine release in NAcc.
Commonly Abused:
Caffeine: Daily consumer rate at 90% in the U.S.
Nicotine: Most frequently used addictive drug.
Ephedrine: Banned by FDA in 2004; used for diet pills, decongestants.
Overview:
Potent natural stimulant from coca leaves.
Historical Use: Documented first use by Incas; major export in South America.
Statistics: 23 million Americans have tried cocaine; 5 million current users.
Health Impact: 5-10% of emergency medical visits linked to cardiac complications from cocaine.
Action:
Cocaine blocks dopamine reuptake, increasing its availability in synaptic cleft.
Key Types:
Dextroamphetamine
Methamphetamine (“speed”, “crystal meth”)
Methylphenidate (Ritalin®)
MDMA (Ecstasy, “Molly”)
Indications:
Attention Deficit Disorders, short-term weight loss, narcolepsy.
Action Mechanism:
Increase dopamine release, block reuptake.
Physiological Effects:
Symptoms include hyperactivity, dilated pupils, restlessness, hypertension, seizures, etc.
Psychological Effects:
Euphoria, aggression, paranoia, potential for amphetamine psychosis in chronic use.
Types:
LSD: Synthetic, derived from morning glory seeds.
Natural Sources: Mescaline from peyote cactus, psilocybin from "magic" mushrooms.
Physiological Effects:
Mydriasis, hyperthermia, hypertension.
Psychological Effects:
Enhanced sensory perception, hallucinations, mood swings.
Mechanism: Agonism at serotonin and dopamine receptors.
Key Component: Tetrahydrocannabinol (THC).
Usage: Predominantly seen in marijuana.
Initial Effects:
Euphoria, laughter, altered time perception.
Later Effects:
Relaxation, difficulty with concentration, memory issues.
Physiological Changes:
Tachycardia, reddened conjunctiva.
How It Works:
THC as an agonist at CB1 and CB2 receptors; interaction with dopamine and serotonin pathways.
Therapeutic Uses:
Used in cancer treatment to reduce nausea and stimulate appetite in AIDS patients.
Types: Morphine, codeine, heroin; natural alkaloids from opium poppy.
Function:
Bind to opiate receptors and inhibit GABA release to enhance dopamine release.
Therapeutic Effects:
Pain relief and euphoria.
Side Effects:
Sleepiness, nausea, slowed breathing, and potential dependency issues.
Neuroimaging Findings:
Methamphetamine users show reduced gray matter in certain areas compared to controls.
Key Concepts:
Understanding of how reward circuits contribute to addiction, including areas like the anterior cingulate cortex and memory systems involving the hippocampus and amygdala.
Withdrawal and Craving Mechanisms:
Activation of reward circuits during craving states and their relationship to reward expectation.